There have been mistakes, yes , especially on the HIV BLA which I wasn’t happy about at all..it was sloppy . But even if people think certain execs aren’t the best, the evidence is pointing to a Dr B.P. selection as CEO if the rumors are true they want to integrate IncellDx with Cytodyn. If that is one of their objectives it is a flawed decision. The whole point of making a change for several longs would be to have an experienced mid to large Pharma ex exec step in those shoes. That’s not Dr P. By a long shot. Being an expert in CCR5 isn’t the same as running a successful Pharma company . So to some who are pushing for this change , be careful what you ask for..